The use of lollipop's new crown rapid detection products can effectively solve the problem of children's new crown detection. Reduce the pain of COVID-19 testing for patients with throat and nose discomfort. Reduce the detection time, and get the results within 20 minutes, which is convenient, quick, and easy to carry. It is conducive to the early detection of patients diagnosed with the new crown.

Specification

COVID-19 Rapid Test Kit.pdf

Can be made as pictured, with individually sealed packaging. Prevent poor infection. Tests are available at home and in public places. Convenient and fast, high accuracy. It can effectively control the spread of the new coronavirus.

Picture details

Why choose Lollipop Rapid Antigen Rapid Test Kit?

We can customize the packaging and add the customer's logo, which is conducive to the customer's brand promotion. The inner packaging is sealed, and the outer packaging is customized. At the same time, it is sanitary, clean, beautiful, and portable.

What are the advantages of saliva testing over nasal swabs?

More portable, you can put it in your mouth like a lollipop. Children, the elderly, and everyone can use it. Open the package and put it in the mouth immediately, reducing cross-infection. More details can be downloaded in the attached PDF.

Why choose us?

Jian's whole commercial enterprise location is extra than 2,000 rectangular meters, consisting of four hundred rectangular meters of GMP 100,000-level purification workshop. Our enterprise is strictly following ISO13485 and ISO9001 pleasant administration machine operation with research, production, best control, finance, home income, and worldwide income, etc. Our merchandise is nicely generic by many customers at home and abroad. In addition, we set up an appropriate enterprise relationship with many home universities and in vitro diagnostic manufacturing enterprises, even with southeast Asia, Europe, Africa, Latin America, and different countries.

Jian has a lookup and improvement crew led by way of a medical practitioner and master with expert employees and a well-equipment facility. The production capability of recombinant antigen has reached 18g/month.